Skip to main content
TipRanks
Go Ultimate75% OFF

UG Healthcare Corp. Ltd. (8K7) Ratios

0 Followers

UG Healthcare Corp. Ltd. Ratios

SG:8K7's free cash flow for Q2 2024 was S$-13.84M. For the 2024 fiscal year, SG:8K7's free cash flow was decreased by S$-1.12M and operating cash flow was S$-12.72M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio2.822.703.834.885.74
Quick Ratio1.611.442.233.224.08
Cash Ratio0.560.450.731.882.70
Solvency Ratio0.11-0.00-0.03-0.350.77
Operating Cash Flow Ratio0.36-0.09-0.48-1.191.45
Short-Term Operating Cash Flow Coverage0.82-0.20-1.01-2.438.72
Net Current Asset ValueS$ 66.34MS$ 62.18MS$ 81.00MS$ 111.13MS$ 160.31M
Leverage Ratios
Debt-to-Assets Ratio0.170.200.190.140.06
Debt-to-Equity Ratio0.240.300.270.170.08
Debt-to-Capital Ratio0.190.230.210.150.07
Long-Term Debt-to-Capital Ratio0.100.120.130.070.04
Financial Leverage Ratio1.401.461.391.271.26
Debt Service Coverage Ratio0.420.06-0.19-1.326.35
Interest Coverage Ratio2.19-0.37-5.17-27.4561.55
Debt to Market Cap0.840.690.560.330.12
Interest Debt Per Share0.070.080.070.050.03
Net Debt to EBITDA1.159.73-3.991.28-1.54
Profitability Margins
Gross Profit Margin28.42%24.11%22.45%1.43%36.28%
EBIT Margin3.68%-0.87%-6.78%-27.14%21.31%
EBITDA Margin7.57%1.72%-3.42%-23.70%22.95%
Operating Profit Margin3.68%-0.57%-5.75%-24.84%21.30%
Pretax Profit Margin2.65%-2.39%-7.89%-28.59%20.96%
Net Profit Margin1.39%-2.63%-5.26%-20.50%15.82%
Continuous Operations Profit Margin1.76%-3.07%-7.56%-27.21%17.11%
Net Income Per EBT52.44%110.29%66.63%71.70%75.46%
EBT Per EBIT72.04%421.57%137.13%115.12%98.42%
Return on Assets (ROA)0.87%-1.63%-2.67%-9.01%12.77%
Return on Equity (ROE)1.22%-2.39%-3.71%-11.47%16.07%
Return on Capital Employed (ROCE)2.90%-0.45%-3.52%-12.74%19.75%
Return on Invested Capital (ROIC)1.72%-0.40%-3.10%-11.17%15.68%
Return on Tangible Assets0.96%-1.78%-2.91%-9.04%12.80%
Earnings Yield4.37%-5.58%-7.96%-23.08%26.97%
Efficiency Ratios
Receivables Turnover2.983.042.262.606.20
Payables Turnover4.244.246.4611.4311.38
Inventory Turnover1.831.701.461.832.40
Fixed Asset Turnover2.332.342.001.693.52
Asset Turnover0.630.620.510.440.81
Working Capital Turnover Ratio1.721.480.980.671.48
Cash Conversion Cycle235.73249.17355.70308.29179.07
Days of Sales Outstanding122.62120.14161.74140.5158.87
Days of Inventory Outstanding199.10215.09250.50199.71152.28
Days of Payables Outstanding85.9986.0756.5431.9432.08
Operating Cycle321.72335.24412.24340.23211.15
Cash Flow Ratios
Operating Cash Flow Per Share0.03-0.01-0.03-0.060.09
Free Cash Flow Per Share0.02-0.01-0.03-0.080.05
Dividend Paid and CapEx Coverage Ratio6.72-1.44-7.11-3.262.29
Capital Expenditure Coverage Ratio6.72-1.44-7.11-4.882.42
Operating Cash Flow Coverage Ratio0.43-0.10-0.42-1.263.00
Operating Cash Flow to Sales Ratio0.12-0.03-0.16-0.390.23
Free Cash Flow Yield31.16%-11.92%-27.21%-52.51%23.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio22.65-17.87-12.57-4.333.71
Price-to-Sales (P/S) Ratio0.320.470.660.890.59
Price-to-Book (P/B) Ratio0.280.430.470.500.60
Price-to-Free Cash Flow (P/FCF) Ratio3.21-8.39-3.68-1.904.31
Price-to-Operating Cash Flow Ratio2.73-14.23-4.19-2.302.53
Price-to-Earnings Growth (PEG) Ratio-0.150.480.180.03-0.05
Enterprise Value Multiple5.3637.23-23.34-2.471.02
Enterprise Value61.14M92.07M91.82M59.21M54.21M
EV to EBITDA5.3637.23-23.34-2.471.02
EV to Sales0.410.640.800.590.23
EV to Free Cash Flow4.08-11.35-4.43-1.261.71
EV to Operating Cash Flow3.48-19.26-5.06-1.511.00
Tangible Book Value Per Share0.240.220.230.290.38
Shareholders’ Equity Per Share0.280.250.260.290.37
Tax and Other Ratios
Effective Tax Rate0.34-0.280.030.050.18
Revenue Per Share0.240.230.180.160.38
Net Income Per Share0.00-0.01-0.01-0.030.06
Tax Burden0.521.100.670.720.75
Interest Burden0.722.741.161.050.98
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.250.250.210.200.11
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality8.381.392.001.891.11

Currency in SGD